Apligraf Versus Standard Therapy in the Treatment of Diabetic Foot Ulcers

Stopped Interruption of business relations between Study Sponsor and Device Manufacturer

Conditions

• Diabetic Foot

Interventions

• DEVICE: Bi-layered cell therapy (Apligraf)

Sponsor

Organogenesis